12 results on '"Pharmacokinetic pharmacodynamic"'
Search Results
2. 413 Pharmacokinetic/pharmacodynamic analysis of OSI-930, a novel selective tyrosine kinase inhibitor with anti-tumor activity
3. 237 Mechanistic pharmacokinetic/pharmacodynamic (PK/PD) modeling of xenograft tumor response of Trastuzumab-DM1-antibody drug conjugates
4. 373 The oral MEK1/MEK2 inhibitor, GSK1120212, effectively inhibits the MAPK pathway: pharmacokinetic, pharmacodynamic, and clinical response relationship
5. 82 Pharmacokinetic–pharmacodynamic modeling of the effect of GDC-0152, a selective antagonist of the inhibitor of apoptosis (IAP) proteins, on monocyte chemotactic protein-1 (MCP-1) indicates species differences in MCP-1 response
6. 573 Eribulin and cytochrome P450 effectors: in vitro studies and population pharmacokinetic–pharmacodynamic analysis
7. 285 POSTER MLN8237, an oral selective Aurora A kinase inhibitor: initial results of dose-finding pharmacokinetic-pharmacodynamic phase I study
8. 4505 ORAL A population pharmacokinetic/pharmacodynamic (PK/PD) analysis of exposure–response for sunitinib in metastatic renal cell carcinoma (mRCC)
9. 709 POSTER Characterization of electrocardiographic QTc interval in patients (pts) with advanced solid tumors: pharmacokinetic–pharmacodynamic evaluation of sunitinib
10. 433 POSTER A population pharmacokinetic/pharmacodynamic model for the hematological effects of BI 2536 in cancer patients
11. 112 Pharmacokinetic-pharmacodynamic (PK-PD) modeling of tumor growth inhibition in mice: a magnetic resonance imaging study
12. 113 Pharmacokinetic-pharmacodynamic (PK-PD) modeling of tumor growth inhibition in mice: the activity of brostallicin is enhanced in cells with high glutathione-S-transferase
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.